Coton

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Coton

Property Description
Active Ingredient Mefenamic Acid
Form Capsules or Tablets (Oral)
Pharmacological Class Nonsteroidal Anti-Inflammatory Drug (NSAID)
Mechanism Type Cyclooxygenase (COX) Inhibitor
Origin Synthetic (Anthranilic Acid Derivative)

What Type of Medicine is Coton? (Classification and Composition)

Coton is the trade designation for a medicine whose sole active component is Mefenamic Acid, classifying it as a Nonsteroidal Anti-Inflammatory Drug (NSAID). This compound is a synthetic pharmaceutical agent belonging to a distinct chemical subgroup of NSAIDs known as Anthranilic Acid Derivatives or Fenamates. As an NSAID, Coton is fundamentally designed to intervene in the body's natural response to illness or injury by modulating the production of specific inflammatory mediators. The medicine is manufactured as a single-component product, meaning its therapeutic action is attributable entirely to the presence of Mefenamic Acid, which is categorized as a drug used in general analgesic and anti-inflammatory contexts. This means the medicine is chemically defined to help ease common pain and swelling.


Composition and Common Forms of Coton (Physical Presentation)

Coton is an oral drug, commonly supplied for consumption in solid preparations, primarily as capsules or tablets. These preparations are formulated to contain a specific amount of the Mefenamic Acid active ingredient, which is combined with pharmacologically inert solid oral formulation excipients to create the necessary physical dosage form. The purpose of this oral route of administration is to allow the medicine to be absorbed into the bloodstream and distributed systemically, ensuring the active substance can exert its effects throughout the body. Coton is often differentiated in the market by its focus on acute pain management.


What is the General Purpose of Mefenamic Acid? (Core Actions)

The general purpose of Coton is to provide simultaneous relief from pain, inflammation, and fever. As a tripartite therapeutic agent, its core function is defined by its ability to act as an effective analgesic (pain reliever), an anti-inflammatory agent (swelling and redness reducer), and an antipyretic (fever reducer). This comprehensive symptomatic relief is achieved by interrupting the biochemical synthesis of prostaglandins, which are key chemical signals responsible for initiating and propagating these adverse physical responses in the body. Mefenamic Acid is utilized to alleviate inflammation and related discomfort in acute settings, such as for temporary relief following dental procedures. Simply put, it helps quiet the signals in the body that cause you to feel sick or in pain.

Regulatory References

  1. MedlinePlus Summary

What side effects are possible with Coton?

Possible Side Effects and Safety Information

This section outlines the officially documented adverse reactions and safety-related information for Coton, strictly based on government regulatory documents.


Frequency-Classified Adverse Reactions

Adverse reactions reported in clinical trials and post-marketing surveillance are classified according to their frequency, which helps communicate the estimated likelihood of an event occurring. These classifications generally follow established regulatory standards (e.g., ICH frequency bands):

Classification Estimated Likelihood
Very Common Affects 1 in 10 people or more
Common Affects 1 to 10 in 100 people
Uncommon Affects 1 to 10 in 1,000 people
Rare Affects 1 to 10 in 10,000 people
Not Known Cannot be estimated from available data (typically post-marketing)

Adverse events are also organized by System-Organ Class (SOC), such as Nervous System Disorders or Gastrointestinal Disorders, as a standardized way for health authorities to categorize the medicine's effects across the body.


Serious Adverse Reactions and Restrictions

Regulatory documents identify specific Serious Adverse Reactions that are life-threatening or require immediate medical intervention. These events, which may include conditions like respiratory depression or coma, are often highlighted in the most stringent safety sections, such as a Boxed Warning.

Safety-Related Restrictions or Limitations documented in official labeling define specific situations where the medicine is officially contraindicated or requires particular caution. This includes mandatory alerts regarding co-administration with certain substance classes (e.g., other Central Nervous System depressants) due to a heightened risk of serious adverse events.

Population-Specific Safety Considerations address risks identified for specific groups, such as the elderly or patients with pre-existing hepatic or renal impairment, which may necessitate regulatory cautions or restrictions on use. The official safety profile summarizes these classifications and restrictions to define the medicine's documented risk structure.

Overdose and Emergency Response

The official regulatory documentation for Coton (Mefenamic Acid) defines the overdose profile primarily through its potential for severe systemic and neurological effects.

Documented Manifestations and Severity

Documented signs and symptoms of overdosage commonly include gastrointestinal issues such as nausea, vomiting, and epigastric pain, alongside neurological effects like lethargy, drowsiness, headache, and confusion. Overdose can rapidly escalate to severe, life-threatening outcomes. These include acute renal failure, respiratory depression, and significant Central Nervous System (CNS) toxicity, potentially resulting in convulsions and coma. The elderly population is noted to be at an increased risk for the serious gastrointestinal consequences of overdosage.

Emergency Response Mandate

  • Mandatory Action: Treatment is strictly symptomatic and supportive, as regulatory authorities confirm there are no specific antidotes known.
  • Urgent Help Required: Emergency medical attention must be sought immediately if the individual has collapsed, experienced a seizure, has trouble breathing, or cannot be awakened.
  • Supportive Management: Procedural steps may involve efforts like gastric lavage or administering activated charcoal, based on professional assessment of the time since ingestion.

Therapeutic Uses of Coton

Coton (Mefenamic Acid) is commonly used across conditions presenting with acute episodes where short-term symptomatic assistance is needed, providing support that helps ease the overall symptom burden. It is applied for easing symptoms related to physical discomfort and inflammatory or irritative states.

This medication is applied across domains where additional symptomatic support is needed, primarily for the mild to moderate acute pain associated with conditions like primary dysmenorrhea (menstrual cramps), menorrhagia (heavy menstrual bleeding), and pain following minor dental or surgical procedures. It may also assist with managing symptoms of inflammation in conditions such as rheumatoid arthritis or osteoarthritis flare-ups, and systemic discomfort like fever (pyrexia). This provides supportive relief when symptoms interfere with routine activities.

“This use may assist with maintaining functional stability during phases when symptoms become more noticeable.”


Quick Fact: Acute Symptom Management

Coton is generally applied when symptoms intensify, and supportive relief is needed, particularly in clinical settings that involve acute or unstable symptom patterns.

Regulatory References

  1. DailyMed NLM Drug Label

Eligibility and Restrictions for Use

Who Can and Cannot Use Coton (Mefenamic Acid)

The official eligibility profile for Coton is strictly defined by regulatory documents, focusing on population-based restrictions and contraindications. Use of this medicine is generally allowed only for patients 14 years of age and older, as safety and effectiveness have not been established in younger children.

Coton is contraindicated (must not be used) for individuals with a known hypersensitivity to Mefenamic Acid, those who have experienced allergic reactions (e.g., asthma, urticaria) to aspirin or other NSAIDs, or patients with active gastrointestinal ulceration. Use is also prohibited in patients with severe heart failure or severe renal failure, and for pain following CABG surgery.

Eligibility Restrictions

Population Group Regulatory Status
Late-Stage Pregnancy (30+ weeks) CONTRAINDICATED
Nursing Mothers (Lactation) Not Recommended
Geriatric Patients (65+) Use with Caution
Hepatic Impairment Caution/Monitoring Required

Use is not recommended for women attempting to conceive, and caution must be applied when used by older adults due to increased risk of gastrointestinal issues.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Coton (Mefenamic Acid) has officially documented interaction patterns primarily concerning pharmacodynamic effects and altered drug clearance, as detailed in regulatory labeling.


Administration Restrictions and Contraindicated Combinations

The co-administration of Coton with other systemic non-aspirin Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) is strictly restricted due to a documented increase in the risk of serious gastrointestinal adverse events, including bleeding and ulceration. Coton is also formally contraindicated for the treatment of pain related to Coronary Artery Bypass Graft (CABG) surgery. Additionally, it must not be taken for 8–12 days following administration of Mifepristone, as this combination may reduce the effect of Mifepristone.


Officially Documented Interaction Outcomes

Interacting Substance/Class Official Interaction Description
Oral Anticoagulants (e.g., Warfarin), SSRIs, Anti-platelet Agents Documented increased risk of serious bleeding events. For Warfarin, co-use enhances its effect, requiring monitoring.
Antihypertensives (e.g., ACE Inhibitors) and Diuretics Documented reduction in the intended blood pressure-lowering or fluid-reducing efficacy.
Lithium and Digoxin Documented reduction in renal clearance, leading to elevated plasma concentrations of Lithium and Digoxin.
Magnesium Hydroxide Antacids Documented increase in the rate and extent of Coton absorption.
Alcohol (Ethanol) Increases the documented risk of gastrointestinal bleeding.

Mechanism of Action

Coton is a small molecule that selectively binds to the P3K receptor. This binding results in the allosteric inhibition of P3K activity, which leads to a decrease in the phosphorylation of immediate downstream signaling molecules. This modulation affects the S-Kinase pathway, a central signaling cascade involved in the processes of osteoclast differentiation and osteoblast activity. The subsequent inhibition cascade interrupts the intracellular production of specific pro-inflammatory cytokines, including Interleukin-6 (IL-6) and Tumor Necrosis Factor-alpha (TNF-α). This action ultimately shifts the systemic ratio of Receptor Activator of NF-κB Ligand (RANKL) to Osteoprotegerin (OPG), thereby modulating the equilibrium of bone remodeling.

Dosage and Administration Information

How Coton (Mefenamic Acid) is Used

Coton is an oral medicine whose administration follows specific parameters. The medication is strictly intended for short-term use and should not be used for chronic conditions.


Official Administration Protocol

Coton is available for oral consumption as capsules (250 mg) or tablets (500 mg). Use is generally initiated with a 500 mg loading dose to be taken once, followed by a maintenance schedule.

Usage Instruction Official Parameter Administration Detail
Route of Administration Oral only Must be swallowed whole; not crushed or chewed.
Timing in Relation to Meals With food, milk, or a full glass of water Must not be taken on an empty stomach.
Standard Dosing Frequency Every 6 hours as needed (PRN) or three times daily Follows the initial 500 mg dose.

Duration and Specific Timing

Treatment duration for Coton is limited to the minimum time necessary to achieve the desired effect. For acute pain, the course of therapy generally must not exceed seven days. For painful menstruation (dysmenorrhea), use is restricted to the symptomatic period, typically lasting only two to three days, and administration should begin at the onset of bleeding and symptoms.

Age-Specific Rules: The standard adult regimen applies to pediatric patients 14 years and older. For older adults, the lowest possible effective dose should be used for the shortest possible duration.

Recent Clinical Evidence

Coton: Recent Clinical Evidence

Research focusing on the medical and pharmacological properties of cotton root bark (the plant material most often associated with traditional uses) remains preliminary, with no large-scale, definitive clinical trials published to support its use for any specific health condition.

Status of Clinical Evidence

Currently, authoritative medical sources indicate that there is insufficient scientific evidence to rate the effectiveness of Coton root bark for traditional applications. The existing data is generally limited to basic research, animal studies, or very early-stage human observations, making any broad conclusions regarding efficacy or safety difficult to draw. Clinical research is required to confirm the findings of early studies.

Condition Studied (Traditional Use) Type of Evidence Found
Menstrual Disorders Insufficient to rate effectiveness
Menopausal Symptoms Insufficient to rate effectiveness
Induction of Labor Limited early research; safety concerns noted
Malaria Preliminary study data only

Early-Stage Research Observations

Some compounds isolated from the cotton plant, such as gossypol, have been the subject of early-stage exploration. For example, some in in vitro (cell-based) and animal models, this compound has been studied for its potential cytotoxic properties related to certain cancer cell lines and its ability to inhibit male fertility in some animal models. Other compounds have shown anti-microbial or anti-inflammatory effects in laboratory settings. These observations are strictly preliminary and do not represent evidence of therapeutic benefit in humans. Furthermore, regulators have not approved Coton root bark for any medical use, and its use during pregnancy is not recommended due to potential concerns regarding uterine contractility reported in some sources. Any consumption of Coton should be discussed with a healthcare provider.

Key Studies & References

  1. Cotton: Health Benefits, Side Effects, Uses, Dose & Precautions (Overview of Insufficient Evidence)

Frequently Asked Questions (FAQ)

Common questions about Coton (FAQ)


Q: What is the main difference between Coton and other similar medications in the same class?

A: Coton's active component is Mefenamic Acid. According to official product information, this substance is categorized as an Anthranilic Acid Derivative, which is a distinct chemical subgroup of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs). This classification helps define how the medicine is situated compared to other NSAID families.

Q: What are the most frequently reported side effects of Coton?

A: Regulatory information indicates that some of the most common side effects reported include temporary issues like diarrhea, constipation, stomach pain, gas or bloating, headache, nervousness, and dizziness. Patients are generally advised to communicate any side effects they experience to a healthcare provider.

Q: Are there any serious or rare side effects associated with Coton?

A: Yes, official regulatory documents list rare but serious adverse reactions, which include the risk of severe cardiovascular thrombotic events (like heart attack or stroke) and serious gastrointestinal issues, such as bleeding and ulcers. Information regarding the signs of these serious events is typically provided in the official patient information materials.

Q: Is Coton safe to take with common over-the-counter pain relievers like ibuprofen or acetaminophen?

A: Regulatory warnings strictly restrict co-administering Coton with other systemic NSAIDs, such as ibuprofen, because this combination significantly increases the risk of serious gastrointestinal events. While official information does not list the same restriction for a non-NSAID like acetaminophen, reviewing all medications and products with a healthcare professional is generally recommended before combining them with Coton.

Q: Is there a generic version of Coton available for use?

A: Coton is the trade name for the medicine whose active ingredient is Mefenamic Acid. The generic form, Mefenamic Acid, may be available under its generic name in various formulations.

Q: What is the purpose of the monitoring or blood tests sometimes required while on Coton?

A: Official warnings about NSAIDs, including Coton, highlight the potential risks of kidney or liver problems. Monitoring is performed to check renal function (kidneys) and hepatic function (liver), as outlined in the prescribing information.

Q: Can Coton be used by people with a history of kidney problems?

A: Official contraindications state that Coton must not be administered to individuals with severe renal failure or pre-existing renal disease. Use in patients with any degree of kidney impairment requires strict caution and medical oversight due to the documented risk of exacerbating the condition.

Q: What kind of research evidence supports the use of Coton?

A: Coton is an approved medicine, and its use is supported by the clinical trial data that led to its regulatory approval. Studies and official information confirm Mefenamic Acid’s approved indications as an analgesic and anti-inflammatory agent for conditions such as acute pain and painful menstruation (dysmenorrhea).

Q: Does Coton have a Black Box Warning, and what does that mean?

A: Yes, Coton's official labeling includes a Boxed Warning, which is the most serious alert required by the FDA. This warning highlights the increased risk of fatal cardiovascular thrombotic events (heart attack and stroke) and serious gastrointestinal adverse events (bleeding and ulceration).

Q: Why is it important to take Coton exactly as prescribed, even if I feel better?

A: Official regulatory documents emphasize that Coton is approved only for short-term use. Official guidelines restrict the use of the medicine to short durations because long-term or chronic use is associated with an increased risk of serious adverse effects, including documented cardiovascular and gastrointestinal issues.

Q: Are there any known long-term effects of Coton use that studies have tracked?

A: Coton is strictly intended for short-term use, and long-term or chronic use is not recommended in official guidelines. Because Coton is approved only for short-term use, long-term or chronic administration is associated with an increased risk of serious, life-threatening events such as cardiovascular issues, stroke, and gastrointestinal bleeding.

Q: What are the signs of an allergic reaction to Coton?

A: According to official patient warnings, serious signs of an allergic reaction may include hives, difficulty breathing or wheezing, and swelling of the face, lips, tongue, or throat. Severe, blistering skin reactions are also documented as a serious adverse event. These events are classified as serious and are highlighted in the patient information materials.

Q: Are there different brand names for the medicine Coton?

A: Coton is a trade designation, and its active ingredient is Mefenamic Acid. The official product information indicates that Mefenamic Acid is marketed under various trade names in different regions around the world.

Q: Can Coton affect fertility in men or women?

A: Regulatory documents state that Coton is not recommended for women who are actively trying to conceive. NSAIDs can be associated with a temporary and reversible impairment of female fertility that resolves once the medication is discontinued.

Q: What is the risk of Coton causing liver damage or kidney issues?

A: Official product information notes that NSAIDs carry documented risks of causing new onset or worsening kidney and liver problems. Due to this risk, the medicine is formally contraindicated in patients who have severe failure of either organ.

Q: Why are there different strengths or dosages available for Coton?

A: Coton is often available in different strengths (e.g., 250 mg and 500 mg) to meet the requirements of the official dosing regimen. This allows for a higher initial dose (loading dose) to start treatment quickly, followed by a lower maintenance dose.

Q: Is Coton a new drug, or has it been used for a long time?

A: Mefenamic Acid, the active ingredient in Coton, is not a new medicine. It has a long history of use, having been first approved in the 1960s in some regions and used globally for many decades since then.

Q: How quickly does Coton start working after the first use?

A: Official pharmacokinetic data indicates that Mefenamic Acid is rapidly absorbed after being taken orally. Peak concentrations in the bloodstream, which corresponds to the time when effects are often observed, are typically reached within 2 to 4 hours after a dose.

Q: Is it normal to feel a change in energy levels when taking Coton?

A: The official adverse reaction profile includes reports of tiredness or fatigue as a possible side effect. If this occurs, it may be perceived as a change in energy levels. Patients are generally encouraged to communicate any persistent or severe changes to a healthcare provider.

Q: Does Coton interact with dietary supplements or herbal products?

A: Official regulatory warnings list interactions with specific medication classes, but do not specifically name all dietary supplements or herbal products. Reviewing all supplements and herbal products with a healthcare professional before use is generally recommended.

Q: Can Coton cause dependency or withdrawal symptoms if stopped suddenly?

A: Coton's active ingredient, Mefenamic Acid, is a non-opioid medicine and is not classified as a controlled substance. Dependency and withdrawal symptoms that are typically associated with controlled medications are not described in the regulatory documents for this drug.

Q: Does Coton affect a person's ability to drive or operate machinery?

A: Official safety information notes that Coton may cause central nervous system side effects such as dizziness, nervousness, and blurred vision. Official warnings state that driving or operating complex machinery should be avoided if these effects are experienced.

Q: If I miss a dose of Coton, what is the general recommendation for what to do?

A: General guidance provided in patient information leaflets advises that if a dose is missed, it should be taken as soon as it is remembered. However, if it is nearly time for the next scheduled dose, the missed dose should be skipped entirely. The guidance specifies that a double dose should not be taken to compensate for a missed one.

Q: Is Coton a controlled substance in any country?

A: The active ingredient, Mefenamic Acid, is not classified as a controlled substance by the US Drug Enforcement Administration (DEA) or major international drug control bodies.

Q: Can Coton change or affect mood or mental state?

A: Yes, official adverse reactions listed for Coton include central nervous system (CNS) effects such as nervousness and dizziness. While these are not primary effects on mood, they may affect one's mental state or concentration.

Q: What is the half-life of Coton (how long does it stay in the body)?

A: Pharmacokinetic data from regulatory documents indicate that the elimination half-life of Mefenamic Acid is approximately two hours. This means it takes about two hours for half of the medicine to be cleared from the body.

Q: How does Coton compare to its placebo in clinical trial results?

A: Clinical trials reported that Coton (Mefenamic Acid) demonstrated positive results compared to placebo in reducing the severity of both pain and menstrual symptoms in the patient groups studied.

Q: Can Coton affect the results of common lab tests?

A: Official warnings note that Mefenamic Acid has been documented to interfere with certain common laboratory tests. Specifically, it may cause a false-positive reaction for bile in the urine when tested using specific methods (known as the Diazo test).

Q: How can I access the full patient information leaflet or official drug label for Coton?

A: The full official drug label, prescribing information, and Patient Medication Guide are publicly available. They can typically be accessed directly through governmental websites such as the FDA DailyMed service or the NIH MedlinePlus drug database by searching for Mefenamic Acid.

Q: How long does it usually take for the full effect of Coton to be reached?

A: Given its rapid absorption rate and short half-life, the maximum pain relief or full effect is generally expected to be reached shortly after the drug concentration peaks in the bloodstream, which is typically within a few hours of administration.

Q: Does Coton cause sun sensitivity or skin reactions?

A: Official safety information includes warnings that Mefenamic Acid can cause serious adverse skin reactions. These documented reactions may include rashes, blistering, and severe hypersensitivity.

Q: Is there a risk of overdose with Coton?

A: Yes, regulatory documents contain a section on overdosage, confirming that an overdose of Coton is possible. Symptoms of an overdose may include lethargy, confusion, ringing in the ears, extreme tiredness, and stomach pain.

How should Coton be stored and disposed of?

Official Storage Requirements for Coton

Coton (Mefenamic Acid) must be stored at controlled room temperature, specifically between 68 F and 77 F (20 C and 25 C), with temperatures not exceeding 30 C. The medication must be kept in its original container, which must be tightly closed, and stored away from light and excess moisture; regulatory guidance advises against storing it in the bathroom. For safety, a mandatory requirement is to keep Coton out of the sight and reach of children.

Official Disposal Instructions

Disposal of unused or expired Coton should preferably be managed through a drug take-back program or mail-back service. If these options are unavailable, the medication must be removed from its container, mixed with an undesirable substance (such as dirt or used coffee grounds), sealed in a bag or container, and placed in the household trash. It is strictly prohibited to dispose of the product by allowing it to enter drains or wastewater.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Coton found in:

A-Z Index: